Market Research Reports- Consulting Analysis Crystal Market Research Synthetic Biology Market

Synthetic Biology Market Size Is Projected
To Be Around $26 Billion By 2025: Crystal
Market Research
A research study titled, Synthetic Biology Market by Product (Oligonucleotide Synthesis, DNA
Synthesis, Standardized DNA Parts, Synthetic Genes, Chassis Organisms) and Application (Agriculture,
Chemicals, Biofuels, Healthcare) - Global Industry Analysis and Forecast to 2025” published by Crystal
Market Research, states that the synthetic biology market is projected to be around $26 billion by
2025.
Synthetic biology refers to interdisciplinary area used for creating new biological parts, devices, and systems
with the help of engineering principles. It can be used to developbio-products, advanced biofuels, renewable
materials, and bio-based specialty chemicals. Synthetic biology can be used to identify and catalog
standardized genomic parts which can be synthesized quickly and used to build novel biological systems. In
natural product synthesis, synthetic biology can be used to produce necessary enzymes along with biological
functions to carry out complex multi-stage production of natural products. In biofuels, synthetic biology can
be used for optimization of genes and microorganisms to efficiently convert feedstock into biofuels. Synthetic
biology is anticipated to witness adoption in varied industries such as agriculture, energy, pharmaceuticals,
and chemicals. In medicine, synthetic biology can be used for manufacturing of drugs, diagnostic agents and
vaccines and in creation of new tissues. In chemical industry, synthetic biology can be used in the production
of fine or bulk chemicals such as proteins to provide a substitute to existing synthetic fibers or natural fibers.
Browse full research report with TOC on “Synthetic Biology Market by Product and Application -
Global Industry Analysis and Forecast to 2025” at:
https://www.crystalmarketresearch.com/report/synthetic-biology-market
Reduction in the cost of DNA sequencing, rise in the development of genetically engineered crops, increased
research and development related expenditure of biotechnology and pharmaceutical companies, growing